http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014532054-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C269-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-14
filingDate 2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2014532054-A
titleOfInvention Process for making compounds useful as inhibitors of ATR kinase
abstract The present invention relates to processes and intermediates for preparing compounds useful as inhibitors of ATR kinases such as aminopyrazine-isoxazole derivatives and related molecules. The present invention also relates to compounds useful as inhibitors of ATR protein kinase. The present invention relates to pharmaceutically acceptable compositions comprising the compounds of the present invention, methods of treating various diseases, disorders and conditions using the compounds of the present invention, processes for preparing the compounds of the present invention, the present It relates to intermediates for the preparation of the compounds of the invention as well as solid forms of the compounds of the invention. The compounds of the invention have the formula I or II, wherein the variables are as defined herein.
priorityDate 2011-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6469002-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010071837-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010017055-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6790935-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008260691-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005123902-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID500987
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID324254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164118004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467217697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465965226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414759479
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8622161
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15270
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID419455
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID734746
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID444528
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3014
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID171239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467341664
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID171239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466481471
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2475
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100139219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86680727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43229
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID36264
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID394048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411968407
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148799020
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID478232
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430105882
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID47396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466743781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141520549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466467344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466999246

Total number of triples: 69.